Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $5.8450 (-18.42%) ($5.8450 - $5.8450) on Fri. Nov. 12, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.53% (three month average) | RSI | 50 | Latest Price | $5.8450(-18.42%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -2.6% a day on average for past five trading days. | Weekly Trend | CGEN advances 1.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(73%) ARKG(70%) ARKK(69%) IWO(67%) IBUY(65%) | Factors Impacting CGEN price | CGEN will decline at least -2.265% in a week (0% probabilities). VIXM(-53%) VXX(-36%) UUP(-11%) TLT(-7%) SHY(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.265% (StdDev 4.53%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $6.46 | 5 Day Moving Average | $6.47(-9.66%) | 10 Day Moving Average | $6.59(-11.31%) | 20 Day Moving Average | $6.46(-9.52%) | To recent high | -18.4% | To recent low | 0.6% | Market Cap | $483m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |